Medicine
Streptomycin 1 g powder for injection
Streptomycin 1 g powder for injection is a generic prescription medicine for intramuscular use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store dry powder at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT Manufactured…
Key facts
- Active ingredient (INN)
- Streptomycin
- Brand
- Sold under the generic name
- Strength
- 1 g
- Dosage form
- Powder for injection
- Route
- Intramuscular
- Packs
- 10 vials
- Manufacturer
- XGen Pharmaceuticals DJB
- Origin register
- US FDA, United States
- Storage
- Store dry powder at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT Manufactured for: XGen Pharmaceuticals DJB, Inc.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07AA04 Streptomycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 June 1998
- Identifiers
- RxCUI 313115DailyMed set ID abd1f64e-4283-4370-aae8-3666316aa36eNDC 39822-0706Application ANDA064210
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 box / 1 injection, powder, lyophilized, for solution in 1 vial | 39822-0706-2 | XGen Pharmaceuticals DJB | 30 June 1998 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Streptomycin is an aminoglycoside antibacterial indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below. MedsAcross supplies Streptomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about StreptomycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Streptomycin prescribing information (XGen Pharmaceuticals DJB) · U.S. National Library of Medicine, DailyMed
Need Streptomycin 1 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.